We now report that MK-2206 induces anti-tumor activity in a subset of human CRC cell lines characterized by their dependence on IGF1R signaling which leads to PI3K/Akt upregulation for cell survival[15]. The gene discussed is IGF1R; the disease is colorectal carcinoma.